Session K: Addressing Gaps to Improve HCV Treatment Access
Tracks
.
| Thursday, September 20, 2018 |
| 11:15 AM - 12:15 PM |
| Sala I |
Speaker
Mrs Stine Nielsen
Epidemiologist
Freelance
Do National HCV Policies In The EU Address Treatment And Care For People Who Inject Drugs?
11:15 AM - 11:30 AMBiography
Stine Nielsen works as a freelance epidemiologist for EMCDDA and other public organisations. She previously worked as an epidemiologist for WHO and the Robert Koch Institute.
Ms. Iuliia Makarenko
Phd Student
Mcgill University
Barriers And Facilitators Of Hepatitis C (HCV) Treatment Initiation Among People Who Inject Drugs In The Era Of New Direct Acting Antivirals
11:30 AM - 11:45 AMBiography
Iuliia Makarenko's research interests include:
Individual and contextual factors related to the transmission of HCV/HIV with a focus on the relationships between mental health problems and injection risk behaviors among people who inject drugs (PWID); and access to HCV care and treatment by PWID.
A/Prof Graham Brown
Research And Evaluation Director
Centre For Social Impact, UNSW
W3 Framework: Understanding The Role And Quality Of Peer Led Programs By People Who Inject Drugs In A National Hepatitis C Response
11:45 AM - 12:00 PMBiography
Dr Graham Brown is a senior research fellow at the Australian Research Centre in Sex, Health and Society, La Trobe University and he primarily works with community and peer led organisations focusing on building evidence for community driven responses to hepatitis C and HIV
Dr. Jennifer Havens
Professor
University Of Kentucky
Knowledge Around Direct Acting Antiviral Therapies And Willingness To Undergo HCV Treatment Among Rural Appalachian Opioid Users
12:00 PM - 12:05 PMBiography
Dr. Jennifer Havens is an infectious diseases epidemiologist at the Center on Drug and Alcohol Research at the University of Kentucky. Her research interests include the infectious complications (HCV/HIV) of injection drug use in rural Appalachia. Dr. Havens has been following a cohort of rural opioid users since 2008.
Lasha Gulbiani
Researcher
Health Research Union
Attitude Of Staff Regarding Integrated Hepatitis C Treatment At Eight Harm Reducation Centers In Georgia
12:05 PM - 12:10 PMBiography
Lasha Gulbiani received his bachelor's degree in public health at Tbilisi State Medical University (TSMU). Currently he is working at Health Research Union as epidemiologist and data manager. He is master's degree student at School of Public Health, TSMU. The topic of his thesis is HCV treatment outcome among PWID.
Dr Eithne Nic An Riogh
Intern
Mater Misericordiae University Hospital, Dublin
Integrating Hepatitis C Care For At-Risk Groups: Findings From A Multi-Centre Observational Study In Primary And Community Care
12:10 PM - 12:15 PMBiography
Dr Eithne Nic an Riogh is recent graduate of Medicine, University College Dublin, Ireland. As a medical intern, Eithne is working in a research role with the HepCare Europe team at the Mater Misericordiae University Hospital, Dublin.
Chair
Tim Rhodes
Professor of Health Sociology
Centre for Social Research in Health, University of New South Wales, Sydney, Australia and London School of Hygiene and
Tessa Windelinckx
Needle Exchange Coordinator Flanders
VZW Free Clinic
